Diagnostics Grand Rounds
Diagnostics Grand Rounds brings clinicians with unmet needs to the Wyss Institute. The goal of these sessions is to inform technology developers about important clinical problems that can help them direct their technology development efforts. Presenters are asked to identify diagnostic needs that will have an impact on the quality of care they deliver.
In this session, Dr. Clemens Scherzer will discuss GBA mutations’ role in the pathogenesis, progression, and treatment of Parkinson’s disease, as well as the function of genetic susceptibility variants vs. generic progression variants in the illness’ pathogenesis, prognostication, and trial design. He will also present opportunity and improvement areas for precision drugs, tailored biomarkers, and precision trials.